Table 2.
Participant demographic and clinical characteristics at baseline.
| Characteristics | eMotion | Control group | Whole sample | |||
|
|
N | Mean (SD) | N | Mean (SD) | N | Mean (SD) |
| Age in years | 32 | 39.3 (12.0) | 30 | 36.9 (12.6) | 62 | 38.1 (12.3) |
| Depression (PHQ-8a) | 32 | 14.4 (3.5) | 30 | 14.8 (2.9) | 62 | 14.6 (3.2) |
| Anxiety (GAD-7b) | 31 | 11.5 (4.7) | 27 | 12.3 (4.2) | 58 | 11.8 (4.5) |
| Min per week of objective MVPAc in 10-min boutsd | 27 | 29.5 (0.0-98.8) | 25 | 42.1 (8.1-93.7) | 52 | 35.8 (0.0-98.6) |
| IPAQ-SF daily min of MVPAd | 27 | 12.9 (0.0-25.7) | 20 | 10.7 (3.6-17.9) | 47 | 12.9 (0.0-25.7) |
aPHQ-8: Patient Health Questionnaire 8.
bGAD-7: General Anxiety Disorder scale.
cMVPA: moderate-to-vigorous intensity physical activity.
dData were positively skewed, so medians (interquartile ranges) are reported.